Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FFBL1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,951
Award facts
- Contract value 100% obligated
- $18,950.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,950.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V represents part of a broader $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors capable of supplying comprehensive pharmaceutical inventories—including branded and generic prescription drugs, biologics, vaccines, and medical consumables—to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a prime vendor contractor reflects its demonstrated performance across numerous delivery orders spanning diverse therapeutic categories and product lines, positioning the company as a critical supplier within the federal military pharmaceutical supply chain. No subcontractors are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FFBL1?
SPE2DR26FFBL1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FFBL1 worth?
The government has obligated $18,951 on SPE2DR26FFBL1.
Is contract SPE2DR26FFBL1 an order under another contract?
Yes. SPE2DR26FFBL1 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBL1 competed?
The extent of competition for SPE2DR26FFBL1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award